Amplify Weight Loss Drug & Treatment ETF (THNR)
NYSEARCA: THNR · Real-Time Price · USD
23.50
0.00 (-0.01%)
Nov 7, 2025, 4:00 PM EST - Market closed
THNR Holdings Information
THNR is an equity ETF with a total of 22 individual holdings. The top holdings are Eli Lilly and Company stock at 15.00%, Novo Nordisk at 10.92%, Regeneron Pharmaceuticals at 7.41%, Amgen at 7.38%, and Chugai Pharmaceutical at 6.51%.
Total Holdings
22
Top 10 Percentage
71.38%
Asset Class
Equity
ETF Category
Health
Assets
2.55M
PE Ratio
19.24
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 15.00% |
| 2 | NVO | Novo Nordisk A/S | 10.92% |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 7.41% |
| 4 | AMGN | Amgen Inc. | 7.38% |
| 5 | TYO: 4519 | Chugai Pharmaceutical Co., Ltd. | 6.51% |
| 6 | AZN | AstraZeneca PLC | 4.89% |
| 7 | MRK | Merck & Co., Inc. | 4.85% |
| 8 | PFE | Pfizer Inc. | 4.85% |
| 9 | ABBV | AbbVie Inc. | 4.82% |
| 10 | SWX: ROG | Roche Holding AG | 4.75% |
| 11 | HKG: 1801 | Innovent Biologics, Inc. | 4.61% |
| 12 | TYO: 4507 | Shionogi & Co., Ltd. | 4.56% |
| 13 | HIMS | Hims & Hers Health, Inc. | 4.14% |
| 14 | HKG: 1093 | CSPC Pharmaceutical Group Limited | 3.54% |
| 15 | CPH: ZEAL | Zealand Pharma A/S | 3.14% |
| 16 | MTSR | Metsera, Inc. | 2.24% |
| 17 | HKG: 1276 | Jiangsu Hengrui Medicine Co., Ltd. | 1.59% |
| 18 | SRRK | Scholar Rock Holding Corporation | 1.39% |
| 19 | KRX: 128940 | Hanmi Pharm. Co., Ltd. | 1.35% |
| 20 | HKG: 3933 | The United Laboratories International Holdings Limited | 1.12% |
| 21 | AGPXX | Short-Term Investment Trust - Invesco Government & Agency Portfolio | 0.75% |
| 22 | n/a | DEPOSITS WITH BROKER FOR SHORT POSITIONS | 0.21% |
As of Nov 5, 2025